SMIHU   $12.15  6.30% Market Closed

Summit Healthcare Acquisition Corp
Last Events:

2023-03-29 Trend pattern changed from нисходящий треугольник to восходящий клин.

2023-03-29 Signal in Stochastic changed from bearish to bullish reversal. The stochastic indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: main and signal line crossing.

2023-03-29 Trend Power changed from strong to slow.

2023-03-29 Trend pattern changed from восходящий клин to нисходящий треугольник.

2023-03-29 Signal in Stochastic changed from bullish reversal to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

2023-03-29 Trend Power changed from slow to strong.

2023-03-28 Trend pattern changed from нисходящий треугольник to восходящий клин.

2023-03-28 Signal in Stochastic changed from bearish to bullish reversal. The stochastic indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: main and signal line crossing.


Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Sell Sell
rsi ActivelyBuy Sell Sell
macd - - -
stoch - - -
ma20 ActivelyBuy ActivelyBuy -
ma50 - - -
ma100 - - -
ISIN KYG8566R1285
ceo Mr. Bo Tan
As of March 16, 2023, Summit Healthcare Acquisition Corp. was acquired by Yisheng Biopharma Co., Ltd., in a reverse merger transaction. Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.